Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
Active, not recruiting · NCT04482894 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute myeloid leukemia, bone marrow disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, myelodysplastic syndrome, myeloid leukemia, neoplasm | Active, not recruiting | Not applicable | 2026-05-04 | NCT04482894 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Virginia | 201 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Virginia | Charlottesville | United States | 136 |